Lorraine Kalia and Suneil Kalia part of ground-breaking research for delivery of therapeutic in Parkinson's disease
LMP's Dr Lorraine Kalia, Associate Professor in the Division of Neurology and Dr Suneil Kalia, Associate Professor in the Division of Neurosurgery are part of a research group leading a world-first clinical trial using focused ultrasound technology to deliver a therapeutic directly to affected brain regions in patients with Parkinson’s disease.
Nov 16 / 2020
LMP's Slava Epelman and Clinton Robbins part of large U of T group receiving funding for COVID-19 research
Dr Clinton Robbins in Laboratory Medicine & Pathobiology (LMP) and Dr Slava Epelman, cross-appointed with LMP and Department of Medicine, Division of Cardiology, are part of a large research group receiving funding from the Canada Foundation for Innovation’s (CFI) Exceptional Opportunities Fund.
Nov 12 / 2020
Coronavirus antibodies can last at least three months after a person becomes infected with the virus that causes COVID-19, according to a study published on October 8 in Science Immunology.Professor Allison McGeer
Oct 13 / 2020
September has brought great recognition to several of our colleagues. We are delighted to announce professors Aubert, Ni and Tsao at the Department of Laboratory Medicine and Pathobiology (LMP) have received distinguished honours.
Sep 30 / 2020